Designing of heterocyclic compounds as promising VEGFR2 tyrosine kinase inhibitors: An Insilico analysis. Int. J. Pharm. Sci. Drug Res. [Internet]. 2021 Nov. 30 [cited 2025 Oct. 16];13(6):685-98. Available from: https://ijpsdronline.com/index.php/journal/article/view/3703